Development and implementation of a medication adherence training instrument for persons living with HIV: The MATI

Behavior Modification

Volumn 29, Issue 2, 2005, Pages 286-317

  McPherson Baker, Shvawn ^a,c   Jones, Deborah ^b   Durán, Ron E ^a,c   Klimas, Nancy ^a,d   Schneiderman, Neil ^a,c,d  

^a UNIVERSITY OF MIAMI   (United States)

^b BARRY UNIVERSITY   (United States)

^c Department of Biology   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Adherence; Highly active retroviral therapy; HIV

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANAMNESIS; ARTICLE; AWARENESS; CLINICAL PROTOCOL; HEALTH CARE; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSTRUMENTATION; INTERPERSONAL COMMUNICATION; MEDICAL INFORMATION; MEDICAL STAFF; MOTIVATION; PATIENT COMPLIANCE; SIDE EFFECT; TRAINING; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BEHAVIOR THERAPY; COOPERATIVE BEHAVIOR; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; MOTIVATION; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT CARE TEAM; PATIENT COMPLIANCE; PHARMACISTS; QUESTIONNAIRES; SICK ROLE;

EID: 16844377912     PISSN: 01454455     EISSN: None     Source Type: Journal    
DOI: 10.1177/0145445504272604     Document Type: Article

References (24)

1. Boden, D., Hurley, A., Zhang, L., Cao, Y., Guo, Y., Jones, E., et al. (1999). HIV-1 drug resistance in newly infected individuals. Journal of the American Medical Association, 282, 1135-1141.
2. Catz, S.L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAuliffe, T. (2000). Patterns, predictors, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124-133.
3. Cheever, L. W., Barnes, G. L., & Chaisson, R. E. (1998, September 24-27). A randomized educational intervention to improve adherence with medication. Interscientific Conference Antimicrobicidal Agents Chemotherapy, 38, 421.
4. Chesney, M. A. (1997, September 4-7). New antiretroviral therapies: Adherence challenges and strategies. Paper presented at Evolving HIV Treatments: Advances and Challenges of Adherence, 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada.
5. Chesney, M. A., Ickovics, J., Hecht, F. M., Sikipa, G., & Rabkin, J. (1999). Adherence: A necessity for successful HIV combination therapy. [Review]. AIDS, 13(Suppl A), S271-S278.
6. Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12(3), 255-266.
7. Deeks, S., Beatty, G., Cohen, P. T., Grant, R., & Volberding, P. (1998, February). Viral load and CD+ T cell changes in patients falling potent protease inhibitor therapy [Abstract]. Paper presented at the 5th Conference on Retroviruses and Opportunistic Infections, Chicago.
8. Epstein, L. H., & Cluss, P. A. (1982). A behavioral medicine perspective on adherence to long-term medical regimens. Journal of Consulting and Clinical Psychology, 50, 950-971.
9. Feste, C., & Anderson, R. M. (1995). Empowerment: From philosophy to practice. Patient Education and Counseling, 26, 139-144.
10. Haynes, R. B. ( 1976). A critical review of the "determinants" of patient compliance with therapeutic regimens. In D. L. Sackett & R. B. Haynes (Eds.), Compliance with therapeutic regimens (pp. 193-279). Baltimore: Johns Hopkins University Press.
11. Kalichman, S. C., Ramachandran, B., & Ostrow, D. (1998). Protease inhibitors and the new AIDS combination therapies: Implications for psychological services. Professional Psychology: Research and Practice, 29, 349-356.
12. Karnofsky, D. A., Abelmann, W. H., Craver, L. F., & Burchehenal, J. H. (1948, November). The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer, (1), 634-656.
13. Maher, K., Klimas, N., Fletcher, M. A., Cohen, V., Maggio, C. M., Triplett, J., et al. (2000). Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an urban Veterans Affairs medical center. Journal of Acquired Immune Deficiency Syndrome, 22(4), 358-363.
14. Malow, R., McPherson, S., Klimas, N., Antoni, M. H., Schneiderman, N., Penedo, F., et al. (1998). Adherence to complex combination antiretroviral therapies by HIV-positive drug abusers. Psychiatric Services, 49, 1021-1024.
15. McPherson-Baker, S., Malow, R. M., Penedo, F., Jones, D. L., Schneiderman, N., & Klimas, N. (2000). Enhancing adherence to combination antiretroviral therapy in non-adherence HIV-positive men. AIDS Care, 12(4), 399-404.
16. Mehta, S., Moore, R. D., & Graham, N. M. (1997). Potential factors affecting adherence with HIV therapy. AIDS, 11, 1665-1670.
17. Nichols-English, G., & Poirier, S. (2000). Optimizing adherence to pharmaceutical care plans. Journal of the American Pharmaceutical Association, 40(4), 475-485.
18. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21-30.
19. Reiter, G. S., Stewart, K. E., & Wojtusik, L. (2000). Elements of success in HIV clinical care: Multiple interventions that promote adherence. Topics in HIV Medicine, 8(5), 21-30.
20. Rosenstock, I. M., Strecher, V. J., & Decker, M. H. (1994). The health belief model and HIV risk behavior change. In J. Peterson & R. DiClemente (Eds.), Preventing AIDS: Theory and practice of behavioral interventions (pp. 5-24). New York: Plenum.
21. Schneiderman, N. (1999). Behavioral management and stress response in HIV/AIDS (February 1998-April 2003). NIH/NIMH-sponsored program project.
22. Sorensen, J. L., Mascovich, A., Wall, T. L., DePhillipis, D., Bakti, S. L., & Chesney, M. (1998). Medication adherence strategies for drug abusers with HIV/AIDS. AIDS Care, 10, 297-312.
23. Wall, T. L., Sorensen, J. L., Batki, S. L., Delucci, K. L., London, J. A., et al. (1995). Adherence to zidovudine (AZT) among HIV infected methadone patients: A pilot study of supervised therapy and dispensing compared to usual care. Drug and Alcohol Dependence, 37, 261-269.
24. Wright, M. T. (2000). The old problem of adherence: Research on treatment adherence and its relevance for HIV/AIDS. AIDS Care, 12(6), 703-710.